Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.

The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.

Ahmad D, Lopez KT, Esmadi MA, Oroszi G, Matteson-Kome ML, Choudhary A, Bechtold ML.

Pancreas. 2014 Apr;43(3):338-42. doi: 10.1097/MPA.0000000000000086.

PMID:
24622061
2.

How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis.

Wan J, Ren Y, Zhu Z, Xia L, Lu N.

BMC Gastroenterol. 2017 Mar 15;17(1):43. doi: 10.1186/s12876-017-0599-4. Review.

3.

A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Sethi S, Sethi N, Wadhwa V, Garud S, Brown A.

Pancreas. 2014 Mar;43(2):190-7. doi: 10.1097/MPA.0000000000000090. Review.

PMID:
24518496
4.

Meta-analysis: rectal indomethacin for the prevention of post-ERCP pancreatitis.

Yaghoobi M, Rolland S, Waschke KA, McNabb-Baltar J, Martel M, Bijarchi R, Szego P, Barkun AN.

Aliment Pharmacol Ther. 2013 Nov;38(9):995-1001. doi: 10.1111/apt.12488. Epub 2013 Sep 16.

5.

Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography.

Thiruvengadam NR, Forde KA, Ma GK, Ahmad N, Chandrasekhara V, Ginsberg GG, Ho IK, Jaffe D, Panganamamula KV, Kochman ML.

Gastroenterology. 2016 Aug;151(2):288-297.e4. doi: 10.1053/j.gastro.2016.04.048. Epub 2016 May 20.

PMID:
27215656
6.

Rectal indomethacin for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials.

Shi N, Deng L, Altaf K, Huang W, Xue P, Xia Q.

Turk J Gastroenterol. 2015 May;26(3):236-40. doi: 10.5152/tjg.2015.6000. Review.

7.

Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis.

Inamdar S, Han D, Passi M, Sejpal DV, Trindade AJ.

Gastrointest Endosc. 2017 Jan;85(1):67-75. doi: 10.1016/j.gie.2016.08.034. Epub 2016 Sep 6. Review.

PMID:
27612923
8.

Indomethacin for post-endoscopic retrograde cholangiopancreatography pancreatitis prophylaxis: is it the magic bullet?

Yang D, Draganov PV.

World J Gastroenterol. 2012 Aug 21;18(31):4082-5. doi: 10.3748/wjg.v18.i31.4082.

9.

Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.

Andrade-Dávila VF, Chávez-Tostado M, Dávalos-Cobián C, García-Correa J, Montaño-Loza A, Fuentes-Orozco C, Macías-Amezcua MD, García-Rentería J, Rendón-Félix J, Cortés-Lares JA, Ambriz-González G, Cortés-Flores AO, Alvarez-Villaseñor Adel S, González-Ojeda A.

BMC Gastroenterol. 2015 Jul 21;15:85. doi: 10.1186/s12876-015-0314-2.

10.

A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis.

Elmunzer BJ, Waljee AK, Elta GH, Taylor JR, Fehmi SM, Higgins PD.

Gut. 2008 Sep;57(9):1262-7. doi: 10.1136/gut.2007.140756. Epub 2008 Mar 28. Review.

PMID:
18375470
11.

Rectal NSAIDs for the prevention of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.

Sun HL, Han B, Zhai HP, Cheng XH, Ma K.

Surgeon. 2014 Jun;12(3):141-7. doi: 10.1016/j.surge.2013.10.010. Epub 2013 Dec 9. Review.

PMID:
24332479
12.

Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and systematic review.

Vadalà di Prampero SF, Faleschini G, Panic N, Bulajic M.

Eur J Gastroenterol Hepatol. 2016 Dec;28(12):1415-1424. Review.

PMID:
27580214
13.

Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.

Mansour-Ghanaei F, Joukar F, Taherzadeh Z, Sokhanvar H, Hasandokht T.

World J Gastroenterol. 2016 Jun 7;22(21):5114-21. doi: 10.3748/wjg.v22.i21.5114.

14.

Can postendoscopic retrograde cholangiopancreatography pancreatitis be prevented by a pharmacological approach?

Cheon YK.

Korean J Intern Med. 2013 Mar;28(2):141-8. doi: 10.3904/kjim.2013.28.2.141. Epub 2013 Feb 27. Review.

15.

A randomized trial of rectal indomethacin and sublingual nitrates to prevent post-ERCP pancreatitis.

Sotoudehmanesh R, Eloubeidi MA, Asgari AA, Farsinejad M, Khatibian M.

Am J Gastroenterol. 2014 Jun;109(6):903-9. doi: 10.1038/ajg.2014.9. Epub 2014 Feb 11.

PMID:
24513806
16.

Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients.

Levenick JM, Gordon SR, Fadden LL, Levy LC, Rockacy MJ, Hyder SM, Lacy BE, Bensen SP, Parr DD, Gardner TB.

Gastroenterology. 2016 Apr;150(4):911-7; quiz e19. doi: 10.1053/j.gastro.2015.12.040. Epub 2016 Jan 9.

17.

Effect of rectal indomethacin for preventing post-ERCP pancreatitis depends on difficulties of cannulation: results from a randomized study with sequential biliary intubation.

Patai Á, Solymosi N, Patai ÁV.

J Clin Gastroenterol. 2015 May-Jun;49(5):429-37. doi: 10.1097/MCG.0000000000000168.

PMID:
25790233
18.

Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis.

Mazaki T, Masuda H, Takayama T.

Endoscopy. 2010 Oct;42(10):842-53. doi: 10.1055/s-0030-1255781. Epub 2010 Sep 30. Review.

PMID:
20886403
19.

Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.

Zheng M, Chen Y, Yang X, Li J, Zhang Y, Zeng Q.

BMC Gastroenterol. 2007 Feb 12;7:6.

20.

[Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes].

Montaño Loza A, Rodríguez Lomelí X, García Correa JE, Dávalos Cobián C, Cervantes Guevara G, Medrano Muñoz F, Fuentes Orozco C, González Ojeda A.

Rev Esp Enferm Dig. 2007 Jun;99(6):330-6. Spanish.

Supplemental Content

Support Center